MedTrace Logo

Impact of LA-CEAL HALT COVID-19 Ambassador Program on Likelihood to Vaccinate

NCT04930965 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2024-01-18

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to assess the effectiveness of the HALT COVID Ambassador educational outreach program on increasing likelihood to vaccinate against COVID-19

Conditions

  • Covid19
  • Vaccine Refusal

Interventions

BEHAVIORAL

Community health worker engagement

3-4 in-person or virtual engagements (individual or group sessions) over 1 month, each engagement lasting 30 minutes to 1 hour

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • Tulane University

    lead OTHER

Principal Investigators

  • Marie Krousel-Wood, MD, MSPH · Tulane University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-10-05
Primary Completion
2022-12-31
Completion
2023-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04930965 on ClinicalTrials.gov